$1.1 Million NIH Phase II SBIR
Aaron recently helped a PI with an emerging pharmaceutical company to win a $1.1 million SBIR Phase II grant from the National Institutes of Health (NIH) to advance their cancer research. The company is developing a theranostic target that has both diagnostic and therapeutic...